T0	Outcomes 4 23	efficacy and safety
T1	Outcomes 199 218	safety and efficacy
T2	Outcomes 647 747	rate of biopsy-confirmed acute rejection (BCAR) and renal function, as measured by serum creatinine.
T3	Outcomes 824 828	BCAR
T4	Outcomes 935 956	Mean serum creatinine
T5	Outcomes 1036 1060	and creatinine clearance
T6	Outcomes 1209 1222	respectively.
T7	Outcomes 1223 1249	Patient and graft survival
T8	Outcomes 1294 1332	differences in infection or malignancy
T9	Outcomes 1423 1522	excellent 12-month patient and graft survival, a low incidence of BCAR, and improved renal function
T10	Outcomes 1616 1642	adequate immunosuppression
T11	Outcomes 1672 1715	for the nephrotoxic effects of cyclosporine